Table 1.
The differences between apoptosis and ferroptosis.
Morphological features | Key biochemical pathway components | |
---|---|---|
Apoptosis | Nuclear rupture, plasma membrane blistering, cell shrinkage, apoptotic body formation and phagocytosis of neighboring cells. | Proapoptotic B-cell lymphoma-2 (BCL-2) family members, caspase activation, cleavage of hundreds of caspase substrates (e. g. intracranial atherosclerotic disease (ICAD), Poly ADP-ribose polymerase (PARP)), phosphatidylserine exposure, Mitochondrial Membrane Potential (△ψm) dissipation, Manganese-Based Tumor Immunotherapy (MOMP) and ROS production. |
Ferroptosis | Smaller mitochondria, reduced condition, increased membrane density, mitochondrial membrane rupture, but normal nucleus. | Iron accumulation, cysteine deprivation, and/or glutathione peroxidase inactivation eventually lead to lipid peroxidation. |